BACKGROUND: Diabetic retinopathy is a microangiopathy of the retina from which nearly all persons with diabetes eventually suffer. Two of its complications threaten the patient's vision: diabetic macular edema and proliferative diabetic retinopathy. METHODS: Selective literature review, based on national and international guidelines and a literature search from 1981 onward. RESULTS: Diabetic retinopathy is subdivided into non-proliferative and proliferative retinopathy. Macular edema can arise at any stage of the disease and threatens visual acuity. The main risk factors for the development and progression of diabetic retinopathy are long duration of diabetes and poor control of blood sugar and arterial blood pressure. Laser photocoagulation is an evidence-based treatment for proliferative retinopathy and macular edema. Vitreous surgery is indicated in cases of worsening vision due to a non-clearing vitreous hemorrhage or tractional retinal detachment. The current options for medical treatment involve the intravitreous injection of glucocorticosteroids or of a VEGF antagonist; both of these options are "off label" at present. CONCLUSION: Diabetic retinopathy is the leading cause of blindness among persons of working age in the industrialized world. Regular ophthalmological examinations, timely laser therapy depending on the stage of the disease, and close interdisciplinary cooperation are essential to prevent loss of vision.
BACKGROUND:Diabetic retinopathy is a microangiopathy of the retina from which nearly all persons with diabetes eventually suffer. Two of its complications threaten the patient's vision: diabetic macular edema and proliferative diabetic retinopathy. METHODS: Selective literature review, based on national and international guidelines and a literature search from 1981 onward. RESULTS:Diabetic retinopathy is subdivided into non-proliferative and proliferative retinopathy. Macular edema can arise at any stage of the disease and threatens visual acuity. The main risk factors for the development and progression of diabetic retinopathy are long duration of diabetes and poor control of blood sugar and arterial blood pressure. Laser photocoagulation is an evidence-based treatment for proliferative retinopathy and macular edema. Vitreous surgery is indicated in cases of worsening vision due to a non-clearing vitreous hemorrhage or tractional retinal detachment. The current options for medical treatment involve the intravitreous injection of glucocorticosteroids or of a VEGF antagonist; both of these options are "off label" at present. CONCLUSION:Diabetic retinopathy is the leading cause of blindness among persons of working age in the industrialized world. Regular ophthalmological examinations, timely laser therapy depending on the stage of the disease, and close interdisciplinary cooperation are essential to prevent loss of vision.
Authors: D V Do; Q D Nguyen; S M Shah; D J Browning; J A Haller; K Chu; K Yang; J M Cedarbaum; R L Vitti; A Ingerman; P A Campochiaro Journal: Br J Ophthalmol Date: 2009-02 Impact factor: 4.638
Authors: A C Keech; P Mitchell; P A Summanen; J O'Day; T M E Davis; M S Moffitt; M-R Taskinen; R J Simes; D Tse; E Williamson; A Merrifield; L T Laatikainen; M C d'Emden; D C Crimet; R L O'Connell; P G Colman Journal: Lancet Date: 2007-11-07 Impact factor: 79.321
Authors: Nish Chaturvedi; Massimo Porta; Ronald Klein; Trevor Orchard; John Fuller; Hans Henrik Parving; Rudy Bilous; Anne Katrin Sjølie Journal: Lancet Date: 2008-09-25 Impact factor: 79.321
Authors: Anne Katrin Sjølie; Ronald Klein; Massimo Porta; Trevor Orchard; John Fuller; Hans Henrik Parving; Rudy Bilous; Nish Chaturvedi Journal: Lancet Date: 2008-09-25 Impact factor: 79.321
Authors: Roy W Beck; Allison R Edwards; Lloyd P Aiello; Neil M Bressler; Frederick Ferris; Adam R Glassman; Elizabeth Hartnett; Michael S Ip; Judy E Kim; Craig Kollman Journal: Arch Ophthalmol Date: 2009-03
Authors: Roland E Schmieder; Stephan Martin; Gabriele E Lang; Peter Bramlage; Michael Böhm Journal: Dtsch Arztebl Int Date: 2009-08-24 Impact factor: 5.594
Authors: J Rosenstock; V Fonseca; J B McGill; M Riddle; J-P Hallé; I Hramiak; P Johnston; M Davis Journal: Diabetologia Date: 2009-06-13 Impact factor: 10.122
Authors: Mehmet Taş; Veysi Oner; Mehmet Fuat Alakuş; Fatih Mehmet Türkcü; Yalçın Işcan; Kemal Yüksel Journal: Int Ophthalmol Date: 2013-01-19 Impact factor: 2.031